SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-002961
Filing Date
2022-03-07
Accepted
2022-03-07 16:56:53
Documents
44
Period of Report
2022-05-06

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20220506xpre14a.htm PRE 14A 2695726
2 GRAPHIC tmb-20220506xpre14a037.jpg GRAPHIC 51761
3 GRAPHIC tmb-20220506xpre14a072.jpg GRAPHIC 3230
4 GRAPHIC tmb-20220506xpre14a020.jpg GRAPHIC 5694
5 GRAPHIC tmb-20220506xpre14a019.jpg GRAPHIC 4648
6 GRAPHIC tmb-20220506xpre14a040.jpg GRAPHIC 3580
7 GRAPHIC tmb-20220506xpre14a009.jpg GRAPHIC 13130
8 GRAPHIC tmb-20220506xpre14a005.jpg GRAPHIC 4041
9 GRAPHIC tmb-20220506xpre14a080.jpg GRAPHIC 62640
10 GRAPHIC tmb-20220506xpre14a055.jpg GRAPHIC 84077
11 GRAPHIC tmb-20220506xpre14a083.jpg GRAPHIC 55111
12 GRAPHIC tmb-20220506xpre14a073.jpg GRAPHIC 630
13 GRAPHIC tmb-20220506xpre14a006.jpg GRAPHIC 4300
14 GRAPHIC tmb-20220506xpre14a027.jpg GRAPHIC 2621
15 GRAPHIC tmb-20220506xpre14a002.jpg GRAPHIC 3359
16 GRAPHIC tmb-20220506xpre14a004.jpg GRAPHIC 2411
17 GRAPHIC tmb-20220506xpre14a016.jpg GRAPHIC 1998
18 GRAPHIC tmb-20220506xpre14a014.jpg GRAPHIC 1949
19 GRAPHIC tmb-20220506xpre14a030.jpg GRAPHIC 3812
20 GRAPHIC tmb-20220506xpre14a034.jpg GRAPHIC 4404
21 GRAPHIC tmb-20220506xpre14a054.jpg GRAPHIC 53738
22 GRAPHIC tmb-20220506xpre14a025.jpg GRAPHIC 4102
23 GRAPHIC tmb-20220506xpre14a026.jpg GRAPHIC 1903
24 GRAPHIC tmb-20220506xpre14a082.jpg GRAPHIC 65644
25 GRAPHIC tmb-20220506xpre14a013.jpg GRAPHIC 1963
26 GRAPHIC tmb-20220506xpre14a032.jpg GRAPHIC 4743
27 GRAPHIC tmb-20220506xpre14a021.jpg GRAPHIC 5187
28 GRAPHIC tmb-20220506xpre14a033.jpg GRAPHIC 4083
29 GRAPHIC tmb-20220506xpre14a081.jpg GRAPHIC 47698
30 GRAPHIC tmb-20220506xpre14a039.jpg GRAPHIC 2878
31 GRAPHIC tmb-20220506xpre14a038.jpg GRAPHIC 3034
32 GRAPHIC tmb-20220506xpre14a036.jpg GRAPHIC 3589
33 GRAPHIC tmb-20220506xpre14a008.jpg GRAPHIC 3410
34 GRAPHIC tmb-20220506xpre14a035.jpg GRAPHIC 2807
35 GRAPHIC tmb-20220506xpre14a031.jpg GRAPHIC 7756
36 GRAPHIC tmb-20220506xpre14a018.jpg GRAPHIC 1644
37 GRAPHIC tmb-20220506xpre14a007.jpg GRAPHIC 4947
38 GRAPHIC tmb-20220506xpre14a024.jpg GRAPHIC 13905
39 GRAPHIC tmb-20220506xpre14a022.jpg GRAPHIC 7544
40 GRAPHIC tmb-20220506xpre14a003.jpg GRAPHIC 3157
41 GRAPHIC tmb-20220506xpre14a023.jpg GRAPHIC 7990
42 GRAPHIC tmb-20220506xpre14a057.jpg GRAPHIC 138731
43 GRAPHIC tmb-20220506xpre14a001.jpg GRAPHIC 37564
44 GRAPHIC tmb-20220506xpre14a012.jpg GRAPHIC 1631
  Complete submission text file 0001558370-22-002961.txt   3726688
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35565 | Film No.: 22718761
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences